share_log

Veeva Introduces Vault Basics for Biotechs

Veeva Introduces Vault Basics for Biotechs

Veeva为生物技术公司推出Vault基础知识
PR Newswire ·  05/16 07:03

Delivers industry-leading Vault applications in a turnkey solution with no implementation costs for simple adoption

以一站式解决方案提供业界领先的 Vault 应用程序,无需实施成本,便于采用

PLEASANTON, Calif., May 16, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced the availability of Veeva Vault Basics, a new offering that includes technology, training, and support designed for biotechs. Vault Basics equips fast-growing companies to deploy industry-leading Veeva Vault applications with zero implementation and maintenance costs. Biotechs can quickly adopt applications built on industry best practices, establishing a foundation to scale and manage growth. Ten biotechs are live with Vault Basics to drive efficiency, speed, and compliance.

加利福尼亚州普莱森顿,2024年5月16日 /PRNewswire/ — Veeva Systems(纽约证券交易所代码:VEEV)今天宣布推出Veeva Vault Basics新产品,包括专为生物技术公司设计的技术、培训和支持。Vault Basics使快速成长的公司能够部署业界领先的Veeva Vault应用程序,而实施和维护成本为零。生物技术公司可以快速采用基于行业最佳实践的应用程序,为扩大规模和管理增长奠定基础。十家生物技术公司正在使用Vault Basics来提高效率、速度和合规性。

"Veeva Vault Basics delivers the complete, pre-validated solution that we need to operate quickly and efficiently as we scale our business," said Phil Adams, senior director of IT at Longboard Pharmaceuticals. "Adding proven technology that was easy to deploy allows us to remain nimble, reducing our ramp-up time, decreasing risk of non-compliance, and improving data quality to accelerate product time to market."

Longboard Pharmicals高级IT董事菲尔·亚当斯表示:“Veeva Vault Basics提供了完整的、经过预先验证的解决方案,这是我们在扩大业务的过程中快速高效地运营所必需的。”“添加易于部署的成熟技术使我们能够保持灵活性,缩短启动时间,降低违规风险,提高数据质量以缩短产品上市时间。”

Veeva Vault Basics delivers industry-leading Vault apps in a turnkey solution for biotechs with no implementation costs.

Veeva Vault Basics以一站式解决方案为生物技术公司提供业界领先的Vault应用程序,无需任何实施成本。

Post this
发布这个

Biotechs using Vault Basics can manage end-to-end processes on Vault applications that are always up to date with the latest features and functionality. Vault Basics is available for North America today and includes:

使用Vault Basics的生物技术公司可以管理Vault应用程序的端到端流程,这些应用程序始终保持最新特性和功能。Vault Basics 现已在北美推出,包括:

  • Vault eTMF Basics to ensure quality, timeliness, and completeness of a clinical trial master file.
  • Vault QualityDocs and Training Basics to drive secure GxP document management and centralize employee training and content.
  • Vault Submissions and Submissions Archive Basics to plan, author, review, and approve regulatory submissions with a complete history of regulatory authority interactions.
  • 保管库 eTMF 基础知识 确保临床试验主文件的质量、及时性和完整性。
  • Vault 质量文档和培训基础知识 推动安全的 GxP 文档管理,集中员工培训和内容。
  • 保管库提交和提交档案基础知识 规划、编写、审查和批准监管机构提交的文件,其中包含监管机构互动的完整历史记录。

"We're applying our deep expertise in life sciences to offer one of the only solutions purpose-built with the simple path biotechs need to scale for growth," said Steve Harper, general manager, Veeva Vault Basics. "With 10 biotechs already signed up and starting to see the benefits of Veeva Vault Basics, we're gaining momentum as more growing companies use Vault with significantly less effort, overhead, and ongoing maintenance."

Veeva Vault Basics总经理Steve Harper表示:“我们正在运用我们在生命科学领域的深厚专业知识,提供仅有的专为生物技术公司扩大规模以实现增长所需的简单路径而构建的解决方案之一。”“已经有10家生物技术公司注册并开始看到Veeva Vault Basics的好处,随着越来越多的成长型公司使用Vault,工作量、开销和持续维护都要少得多,我们的势头正在增强。”

Additional Vault Basics offerings are planned for availability in 2025. For more on Vault Basics, visit veeva.com/VaultBasics.

其他保管库基础知识产品计划于 2025 年上市。有关 Vault 基础知识的更多信息,请访问 veeva.com/VaultBasics。

About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

关于 Veeva 系统公司
Veeva是生命科学行业云软件领域的全球领导者。Veeva致力于创新、产品卓越和客户成功,为1,000多家客户提供服务,包括全球最大的生物制药公司和新兴生物技术公司。作为一家公益公司,Veeva致力于平衡所有利益相关者的利益,包括客户、员工、股东及其所服务的行业。欲了解更多信息,请访问 veeva.com。

Veeva Forward-looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-K for the fiscal year ended January 31, 2024, which you can find here (a summary of risks which may impact our business can be found on pages 9 and 10), and in our subsequent SEC filings, which you can access at sec.gov.

Veeva 前瞻性声明
本新闻稿包含有关Veeva产品和服务以及使用我们的产品和服务的预期结果或收益的前瞻性陈述。这些陈述基于我们当前的预期。实际结果可能与本新闻稿中提供的结果存在重大差异,我们没有义务更新此类声明。有许多风险可能会对我们的业绩产生负面影响,包括我们在截至2024年1月31日的财年10-K表中披露的风险和不确定性,你可以找到这些风险和不确定性 这里 (可能影响我们业务的风险摘要见第 9 页和第 10 页),以及我们随后提交的美国证券交易委员会文件,您可以访问这些文件 sec.gov

Contact:

联系人:

Deivis Mercado
Veeva Systems
925-226-8821
[email protected]

Deivis Mercado
Veeva 系统
925-226-8821
[电子邮件保护]

SOURCE Veeva Systems

来源 Veeva Syst

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发